Alzheimer’s Drug Discovery Foundation Chief Executive Officer Mark Roithmayr Announces Retirement in 2025
Hand-out
Press Releases
April 26, 2025

Alzheimer’s Drug Discovery Foundation Chief Executive Officer Mark Roithmayr Announces Retirement in 2025

NEW YORK, April 24, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that Mark Roithmayr will retire from his role as Chief Executive Officer effective December 31,

bradford

The Bradford Era

Local & Social